Last reviewed · How we verify

NCT05585528: INFO-LCA

Informing the Patient on the Type of Management, Surgical or Functional, After Rupture of the Anterior Cruciate Ligament

Terminated NA Last updated 6 April 2026
What this trial tests

NA trial testing Functional or surgical management in 1st intention in Ligament Rupture in 106 participants. Terminated before completion.

Timeline
20 December 2022
Primary endpoint
29 March 2026
29 March 2026

Quick facts

Lead sponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment106
Start date20 December 2022
Primary completion29 March 2026
Estimated completion29 March 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche — full company profile →

Who can join

18 and older, any sex, with Ligament Rupture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to evaluate the proportion of patients after rupture of the anterior cruciate ligament (ACL) of the knee, who will have functional or surgical management (PEC) in 1st intention, after having received appropriate information.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other GCS Ramsay Santé pour l'Enseignement et la Recherche trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05585528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing